The Functional Basis of Ocular Dominance: Functional MRI (fMRI) Findings
Overview
Authors
Affiliations
Changes in cortical metabolism and cerebral perfusion may be recorded non-invasively with functional magnetic resonance imaging (fMRI). In pilot experiments, using fMRI with photic stimulation, we found differences between activated areas when the left or the right eye was stimulated separately. In this study we investigated whether this could be explained by ocular dominance. We studied 26 healthy volunteers (mean age 23.3 +/- 3.5 years). Ocular dominance was determined by means of the near-far alignment test. fMRI-measurements consisted of a double-slice gradient echo sequence. Slices were acquired placed parallel on either side of the calcarine fissure. Visual stimulation was done with goggles with two LED matrices (red light, 8 Hz); each in front of one eye. In each subject, the left and right eye were stimulated separately and together, in a randomly alternating order. Twenty-two subjects showed activation, of whom eight subjects had a dominant left eye and 14 a dominant right eye. In general the size of the activated area was bigger upon stimulation of the dominant eye. The difference with the area upon stimulation of the non-dominant eye was statistically significant in the right eye dominant group. These results indicate that the dominant eye actually activates a larger area of the primary visual cortex than the non-dominant eye. This provides for the first time a functional basis for the concept of ocular dominance.
Monocular blur impairs heading judgements from optic flow.
Sheppard W, Coats R, Wilkie R, Baraas R Iperception. 2025; 16(1):20416695251317148.
PMID: 40012959 PMC: 11863211. DOI: 10.1177/20416695251317148.
Hamurcu M, Polat Gultekin B, Tuncer Gocmen M, Mendi Z Doc Ophthalmol. 2024; 150(1):17-23.
PMID: 39733371 DOI: 10.1007/s10633-024-10001-2.
Cortical Reorganization After Optical Alignment in Strabismic Patients Outside of Critical Period.
Huang Y, Liu Z, Wang M, Gao L, Wu Y, Hu J Invest Ophthalmol Vis Sci. 2023; 64(11):5.
PMID: 37535007 PMC: 10408769. DOI: 10.1167/iovs.64.11.5.
Robert R, Babu M, Unnikannan K Beyoglu Eye J. 2023; 8(2):104-109.
PMID: 37521883 PMC: 10375208. DOI: 10.14744/bej.2023.46504.
Huang Y, Liu Z, Chen Z, Zhan Z, Gao L, Hu J Invest Ophthalmol Vis Sci. 2023; 64(1):10.
PMID: 36652265 PMC: 9855284. DOI: 10.1167/iovs.64.1.10.